Sitejabber review of the streetsweeper: This website

New Post Public Reply Private Reply Replies (0) Message Board
Expose
Sitejabber review of the streetsweeper: This website attempts to portray itself as a legitimate website that educates the public about potential corporate fraud and schemes when in actuality it is a website that is used by its editor and contributors to target smaller start up companies by loosely fabricating stories whose primary purpose is to create panic and induce stockholders to sell stock that TheStreetSweeper.org and its conspirators have issued short sell orders.

This is further demonstrated by separate articles on the StreetSweeper in their first article disclaimer they indicated they have shorted the stock, and in the second article disclaimer, they state that they don't have any interest, but the disclaimer on the website prettymuch says it all in that their objectivity in their articles is slanted by profit sharing (short/long) positions that they establish.

=== Website Disclaimer

ADDITIONALLY, STREET SWEEPER WILL FROM TIME TO TIME HAVE PROFIT-SHARING ARRANGEMENTS WITH THIRD PARTIES OR OTHERS WHO WILL TAKE LONG OR SHORT POSITIONS IN STOCKS REFERRED TO IN THIS NEWSLETTER. THESE POSITIONS AND/OR ARRANGEMENTS WILL AFFECT OUR OBJECTIVITY.

Which in essence means that they will use their blog to manipulate stockholder sentiment in order to cover their short positions.


=====Disclalimer below is from their first article
* Important Disclosure: TheStreetSweeper, through its members, began establishing a short position in Miller Energy Resources (MILL) on June 24 and has now shorted a total of 129,431 shares of the company's stock at an average price of $7.07 a share. It expects to profit on future declines in the stock by covering its short position at a lower price and will fully disclose the details of its transactions as they occur.

Update: TheStreetSweeper covered 39,500 shares of MILL on July 28 at $5.42 a share. It covered the remaining 89,931 shares of its short position in MILL on July 28 at $3.76 a share and no longer has a position in the company's stock. TheStreetSweeper may choose to establish a new short position in MILL in the future and will promptly disclose the details of any additional transactions in the company's stock if and when they occur.

As a matter of policy, TheStreetSweeper prohibits members of its editorial staff from taking financial positions in the companies that they cover. To contact Melissa Davis, the editor of this website and the primary author of this story, please send an email to editor@thestreetsweeper.org.

Disclaimer below is from their second article=================================

* Important Disclosure: TheStreetSweeper currently holds no financial position in the stock of Miller Energy Resources. As previously disclosed, TheStreetSweeper established a short position in the stock before publishing its original investigative report on the company. However, it has already covered that entire position and has executed no additional trades in the securities since that time.

As a matter of policy, TheStreetSweeper prohibits members of its editorial staff from taking financial positions in the companies they cover. To contact Melissa Davis, the editor of this website and the author of this story, please send an email to editor@thestreetsweeper.org.

http://www.sitejabber.com/reviews/www.thestreetsweeper.org

KMA Global Solutions International, Inc. (KMAG) Stock Research Links

KMAG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmVira's Bladder Cancer Trials: Promising Data Revealed

Updated Category News Views 3

Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...

Continue Reading
Resilience: From Trauma to Shielding Powerhouses

Updated Category News Views 6

A Childhood Steeped in Shadows If you think it's all Wall Street pulse for me, think again. Sometimes you stumble upon stories that hit the gut with more force than any market crash. Enter David Seymour's tale, wrapped up in his newly released autobiography from Palmetto Publishing, bearing the intriguingly gritty title: From paperboy to Secret Service Special Agent. This...

Continue Reading
ThreatLocker Launches Global AI Awareness Campaign

Updated Category News Views 4

Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...

Continue Reading
Camel Group Expands Battery Portfolio at Canton Fair

Updated Category News Views 3

A Grand Display at the Canton Fair Well, here's one you don't see every day: Camel Group putting on quite the show at the 140th China Import and Export Fair, better known to us as the Canton Fair. Kicked off on October 15, 2026, in Guangzhou, this grand event paraded 'Advanced Manufacturing' as its theme, and Camel's booth was packed to the brim with what might just be...

Continue Reading
ZPMC's Wind Power and Port Projects Earn Top Honors

Updated Category News Views 1

Wind Farms and Ports: A Winning Formula National applause rings out for Shanghai Zhenhua Heavy Industries Co., Ltd. (ZPMC) as they snagged top honors in the recent National Quality Engineering Awards. It's about time folks recognized the heavy lifting these projects do in reshaping our energy and port infrastructure. Two of their standout projects walked away with...

Continue Reading
Encompass Health Expands With Texas Rehab Hospital

Updated Category News Views 6

A New Chapter in San Antonio's Healthcare Landscape Breaking ground in Texas, Encompass Health has unveiled its latest addition: a 50-bed hospital in San Antonio's Westover Hills. With sheer determination, the largest owner of inpatient rehabilitation hospitals in the U.S. has made its mark, and this isn't just any facility—at over 54,000 square feet, it's a hub for...

Continue Reading
Union Alarmtronic Joins Forces with Pye-Barker in Key Sale

Updated Category News Views 3

A Key Merger in Security Sector Here's a deal that's got the market talking: Union Alarmtronic, a stalwart in the security systems arena, has tied the knot with Pye-Barker Fire & Safety, one of the biggest names in fire protection and life safety. This move isn't just another line in the 'mergers & acquisitions' logbook; it's a strategic shift that underscores the growing...

Continue Reading
Duni Group Faces Ups and Downs in Q3 2026

Updated Category News Views 1

Navigating Choppy Waters: Duni's Third Quarter 2026 Alright, folks, let's dive into the latest from Duni Group—a company feeling the pinch but pushing through with some resilience. The third quarter 2026 report has just landed, and while some numbers are headed up, plenty are a bit of a gut punch. This isn't a crisis, but it's no smooth sailing either. Let's cut through...

Continue Reading
Groundbreaking Sale: Lani Automotive Acquires Iowa Dealership

Updated Category News Views 6

A shift in the automotive retail world takes place with Lani Automotive Group's latest move. They've just picked up their first franchised dealership, Mount Pleasant Chevrolet GMC Chrysler Dodge Jeep Ram in Iowa. It's a mouthful, sure, but it packs a punch in terms of potential growth. Why This Sale Stands Out The deal was brokered by Performance Brokerage Services, which...

Continue Reading
Marengo: Bold Moves in TMB-H Tumor Treatment

Updated Category News Views 0

A New Hope for Tough Tumors? Marengo Therapeutics is stirring up the oncology world with some intriguing Phase 2 results from their STARt-001 clinical trial, revealing invikafusp alfa's potential as a single-agent therapy. This hasn’t been a walk in the park, mind you; we're talking about dealing with TMB-H solid tumors that typically thumb their noses at immune...

Continue Reading
iv>